YM155, a novel survivin suppressant, demonstrates anti-tumor activity in patients with advanced solid tumors and non-Hodgkin's lymphoma
ANNALS OF ONCOLOGY(2006)
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined